Rapid Screening Tests for Determining In Vitro Susceptibility of Herpes Simplex Virus Clinical Isolates
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Com...
Saved in:
Published in | Journal of Clinical Microbiology Vol. 36; no. 8; pp. 2389 - 2391 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.08.1998
|
Series | Note |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
|
---|---|
AbstractList | The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 μg of ACV per ml for HSV-1 and HSV-2, respectively) in two rapid assays: a rapid cytopathic effect inhibitory assay (Rapid CIA) and a rapid dye uptake assay (Rapid DUA). These tests allow the simultaneous determination of virus titer and susceptibility to ACV at a determined viral concentration (100 50% tissue culture infective doses and 100 50% dye uptake units). These tests were compared with a conventional susceptibility assay (dye uptake assay) and showed similar results. Indeterminate results with the Rapid CIA appeared in 3 of 30 samples. With the use of both Rapid CIA and Rapid DUA, we were able to determine the susceptibility of 100% of the isolates. The rapid tests, unlike conventional assays, are able to provide susceptibility results within 3 days after the virus has been isolated from a clinical specimen and could thus play a direct role in therapeutic decisions. The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 micrograms of ACV per ml for HSV-1 and HSV-2, respectively) in two rapid assays: a rapid cytopathic effect inhibitory assay (Rapid CIA) and a rapid dye uptake assay (Rapid DUA). These tests allow the simultaneous determination of virus titer and susceptibility to ACV at a determined viral concentration (100 50% tissue culture infective doses and 100 50% dye uptake units). These tests were compared with a conventional susceptibility assay (dye uptake assay) and showed similar results. Indeterminate results with the Rapid CIA appeared in 3 of 30 samples. With the use of both Rapid CIA and Rapid DUA, we were able to determine the susceptibility of 100% of the isolates. The rapid tests, unlike conventional assays, are able to provide susceptibility results within 3 days after the virus has been isolated from a clinical specimen and could thus play a direct role in therapeutic decisions. ABSTRACT The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 μg of ACV per ml for HSV-1 and HSV-2, respectively) in two rapid assays: a rapid cytopathic effect inhibitory assay (Rapid CIA) and a rapid dye uptake assay (Rapid DUA). These tests allow the simultaneous determination of virus titer and susceptibility to ACV at a determined viral concentration (100 50% tissue culture infective doses and 100 50% dye uptake units). These tests were compared with a conventional susceptibility assay (dye uptake assay) and showed similar results. Indeterminate results with the Rapid CIA appeared in 3 of 30 samples. With the use of both Rapid CIA and Rapid DUA, we were able to determine the susceptibility of 100% of the isolates. The rapid tests, unlike conventional assays, are able to provide susceptibility results within 3 days after the virus has been isolated from a clinical specimen and could thus play a direct role in therapeutic decisions. The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 mu g of ACV per ml for HSV-1 and HSV-2, respectively) in two rapid assays: a rapid cytopathic effect inhibitory assay (Rapid CIA) and a rapid dye uptake assay (Rapid DUA). These tests allow the simultaneous determination of virus titer and susceptibility to ACV at a determined viral concentration (100 50% tissue culture infective doses and 100 50% dye uptake units). These tests were compared with a conventional susceptibility assay (dye uptake assay) and showed similar results. Indeterminate results with the Rapid CIA appeared in 3 of 30 samples. With the use of both Rapid CIA and Rapid DUA, we were able to determine the susceptibility of 100% of the isolates. The rapid tests, unlike conventional assays, are able to provide susceptibility results within 3 days after the virus has been isolated from a clinical specimen and could thus play a direct role in therapeutic decisions. Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JCM RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0095-1137 Online ISSN: 1098-660X Copyright © 2014 by the American Society for Microbiology. For an alternate route to JCM .asm.org, visit: JCM |
Author | Maria I. Blanco Maria de Oña Mercedes Rodriguez Santiago Melón Pedro de la Iglesia Beatriz López Purificación Mellado |
AuthorAffiliation | Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain |
AuthorAffiliation_xml | – name: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain |
Author_xml | – sequence: 1 givenname: P surname: DE LA IGLESIA fullname: DE LA IGLESIA, P organization: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain – sequence: 2 givenname: S surname: MELON fullname: MELON, S organization: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain – sequence: 3 givenname: B surname: LOPEZ fullname: LOPEZ, B organization: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain – sequence: 4 givenname: M surname: RODRIGUEZ fullname: RODRIGUEZ, M organization: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain – sequence: 5 givenname: M. I surname: BLANCO fullname: BLANCO, M. I organization: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain – sequence: 6 givenname: P surname: MELLADO fullname: MELLADO, P organization: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain – sequence: 7 givenname: M surname: DE ONA fullname: DE ONA, M organization: Laboratorio de Virología, Servicio de Microbiologia, Hospital Covadonga, 33006 Oviedo, Asturias, Spain |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2353924$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9666034$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkkuP0zAUhS00aOgUfgLCSIhdgh0_Yi9YoPKYokFIdEDsLI9703qUxMFOgPn3OLQqsGJl6d7v2Pee4wt01oceEHpCSUlppV7cuq5kslRlxZQuKqZpSbVW99CCEq0KKcnXM7QgRIuCUlY_QBcp3RJCORfiHJ1rmQnGF2j3yQ5-izcuAvS-3-FrSGPCTYj4NYwQO_-7uu7xFz_GgDdTcjCM_sa3frzDocGXEAdIeOO7oYWfGYtTwqs265xt8TqF1o6QHqL7jW0TPDqeS_T57Zvr1WVx9fHdevXqqnBc12Ph8sC0riupa-5coyqhBYADKiiwZquo41VTa24V45RtGyEl8C3jUksQtZRsiV4e7h2mmw62Dvox2tYM0Xc23plgvfm30_u92YXvhhJBsiVL9Pyoj-HblL0wnc8bt63tIUzJqOyhVqT-L0ilqGTOJYP1AXQxpBShOQ1DiZmzNO9XHwyTRpk5SzNnaeYss_Lx37ucdMfwcv_ZsW9T9rqJtnc-nbCKCaarGXt6wPZ-t__hIxibOpM_0J9H2S-pHbZG |
CODEN | JCMIDW |
CitedBy_id | crossref_primary_10_1128_CDLI_9_6_1379_1381_2002 crossref_primary_10_1078_094471102321616463 crossref_primary_10_1007_s11274_009_0147_7 crossref_primary_10_1016_j_ijpharm_2005_11_025 crossref_primary_10_3390_ijms222011013 crossref_primary_10_1016_S0255_0857_21_02118_6 crossref_primary_10_1590_abd1806_4841_20142574 crossref_primary_10_1016_S0166_3542_99_00039_X crossref_primary_10_1016_S0166_0934_02_00103_9 crossref_primary_10_1128_AAC_44_4_873_878_2000 |
Cites_doi | 10.1128/AAC.31.10.1465 10.1056/NEJM199209103271108 10.1016/0166-3542(83)90001-3 10.1093/jac/12.suppl_B.137 10.1128/AAC.36.8.1589 10.7326/0003-4819-76-3-112-6-416 10.1056/NEJM199312093292405 |
ContentType | Journal Article |
Copyright | 1998 INIST-CNRS Copyright © 1998, American Society for Microbiology 1998 |
Copyright_xml | – notice: 1998 INIST-CNRS – notice: Copyright © 1998, American Society for Microbiology 1998 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
DOI | 10.1128/jcm.36.8.2389-2391.1998 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database AIDS and Cancer Research Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1098-660X |
EndPage | 2391 |
ExternalDocumentID | 10_1128_JCM_36_8_2389_2391_1998 9666034 2353924 jcm_36_8_2389 |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 08R 0R~ 18M 29K 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS AAUGY AAYOK ABOCM ABPPZ ACGFO ADBBV AENEX AFMIJ AGCDD AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CS3 D-I DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HF~ HYE HZ~ H~9 IQODW KQ8 L7B O9- OHT OK1 P2P P6G RHF RHI RNS RPM RSF TR2 UCJ VH1 W8F WHG WOQ X7M ZA5 ZCA ZGI ZXP ~KM AGVNZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
ID | FETCH-LOGICAL-c497t-c09517726974ccf82595eece151e3fd81c42f794a83413df566e4d34696e57663 |
IEDL.DBID | RPM |
ISSN | 0095-1137 |
IngestDate | Tue Sep 17 21:06:41 EDT 2024 Fri Oct 25 11:42:09 EDT 2024 Fri Oct 25 00:59:28 EDT 2024 Thu Sep 12 17:24:02 EDT 2024 Sat Sep 28 07:35:03 EDT 2024 Sun Oct 29 17:09:42 EDT 2023 Wed May 18 15:25:49 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Virus Performance evaluation Acyclic nucleoside Purine nucleoside Drug susceptibility test Herpesviridae Alphaherpesvirinae Aciclovir Antiviral Herpesvirus hominis Comparative study |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c497t-c09517726974ccf82595eece151e3fd81c42f794a83413df566e4d34696e57663 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Corresponding author. Mailing address: Laboratorio de Virología, Servicio de Microbiología, Hospital Covadonga, Celestino Villamil, s. n., 33006 Oviedo, Asturias, Spain. Phone: 34-8-5108720. Fax: 34-8-5108015. E-mail: virologia@hcq.es. |
OpenAccessLink | https://jcm.asm.org/content/jcm/36/8/2389.full.pdf |
PMID | 9666034 |
PQID | 16526239 |
PQPubID | 23462 |
PageCount | 3 |
ParticipantIDs | pubmed_primary_9666034 proquest_miscellaneous_16526239 highwire_asm_jcm_36_8_2389 crossref_primary_10_1128_JCM_36_8_2389_2391_1998 pubmedcentral_primary_oai_pubmedcentral_nih_gov_105060 proquest_miscellaneous_80019807 pascalfrancis_primary_2353924 |
PublicationCentury | 1900 |
PublicationDate | 1998-08-01 |
PublicationDateYYYYMMDD | 1998-08-01 |
PublicationDate_xml | – month: 08 year: 1998 text: 1998-08-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationSeriesTitle | Note |
PublicationTitle | Journal of Clinical Microbiology |
PublicationTitleAlternate | J Clin Microbiol |
PublicationYear | 1998 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | 2829708 - Antimicrob Agents Chemother. 1987 Oct;31(10):1465-9 8232486 - N Engl J Med. 1993 Dec 9;329(24):1777-82 2155570 - Ann Intern Med. 1990 Mar 15;112(6):416-22 6313593 - J Antimicrob Chemother. 1983 Sep;12 Suppl B:137-52 6320716 - Antiviral Res. 1983 Nov;3(4):223-34 1288525 - N Engl J Med. 1992 Sep 10;327(11):782-9 1416838 - Antimicrob Agents Chemother. 1992 Aug;36(8):1589-95 e_1_3_2_9_2 e_1_3_2_8_2 e_1_3_2_7_2 e_1_3_2_6_2 e_1_3_2_5_2 e_1_3_2_4_2 e_1_3_2_3_2 e_1_3_2_2_2 |
References_xml | – ident: e_1_3_2_5_2 – ident: e_1_3_2_8_2 doi: 10.1128/AAC.31.10.1465 – ident: e_1_3_2_9_2 doi: 10.1056/NEJM199209103271108 – ident: e_1_3_2_7_2 doi: 10.1016/0166-3542(83)90001-3 – ident: e_1_3_2_3_2 doi: 10.1093/jac/12.suppl_B.137 – ident: e_1_3_2_2_2 doi: 10.1128/AAC.36.8.1589 – ident: e_1_3_2_4_2 doi: 10.7326/0003-4819-76-3-112-6-416 – ident: e_1_3_2_6_2 doi: 10.1056/NEJM199312093292405 |
SSID | ssj0014455 |
Score | 1.6526964 |
Snippet | Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 micrograms of ACV... ABSTRACT The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 μg of ACV... The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 mu g of ACV per ml... The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 μg of ACV per ml... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2389 |
SubjectTerms | Acyclovir - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal agents Antiviral Agents - pharmacology Biological and medical sciences Cells, Cultured Herpes Simplex - virology Herpesvirus 1, Human - drug effects Herpesvirus 1, Human - growth & development Herpesvirus 2, Human - drug effects Herpesvirus 2, Human - growth & development Humans Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments Virology |
Title | Rapid Screening Tests for Determining In Vitro Susceptibility of Herpes Simplex Virus Clinical Isolates |
URI | http://jcm.asm.org/content/36/8/2389.abstract https://www.ncbi.nlm.nih.gov/pubmed/9666034 https://search.proquest.com/docview/16526239 https://search.proquest.com/docview/80019807 https://pubmed.ncbi.nlm.nih.gov/PMC105060 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH6ik4Z2QTCYyGDDB65J4_hHneNUGN2kIkQ31JuVOA4LWtOqaSX23-85cQpFcOEaO7bi7znve_Ln9wDe25RxJS0LWZ7nIbcp7rlM8FBZIcwoycq8zdM9_Swnt_x6Lub-UljjZZW1yauovl9EdXXXaitXCzPsdWLDL9MxcoJYxsMBDNA--wjdnxxwLrqqBakIKWUjr-nC3_Dwh1lETEYqQjeVhglLqburp47gEDm_jBnf9019vmAnl8waXLGyK3XxNy76p6TyNx91-RyeeXJJLrqPeAFPbH0Mh125yYdjeDr1B-kv4fvXbFUVZGac7Aa9F7nBeRqCDJZ88AIZ9_SqJt-qzXpJZtum1b-0UtoHsizJxK5XtiGzyqUX_ond1tuG-Cyj9-QKTdqx2Fdwe_nxZjwJfc2F0PB0tAmNo1zIuCXGGcaUGD-mwlpjkRhYVhaKGp6UuIcz5dxfUSIbtLxgGGRLi6GLZCdwUC9r-xqIK4uEETBVjqYZznPDckkNLbIC52A8gLhfbb3qUmvoNiRJlL4eTzWTWmkHlXZQaQdVAKc9KjprFhoR_dUtgLM9nHaDJkwgC8T53vW4adxD7mAkq-1y22gqRYI0MP13D-WosIpHAZx0OO8G96YTgNwzgF27S9-934JW3abx7qz49H9ffANH3f1IJ0Z8Cweb9daeIUHa5Ocw-DSn5-2-eATVkw7u |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH6CocEu_BhMZDDmA9ekSey4zhEVpnasE6It2s1KHAcCa1o1icT463lOnEInOMA1duIk_p7f9-TP7wG81jFlgmvq0jRNXaZjtLkkYq7QUaSGYZKnbZ7u6SUfL9j5VXRlD4VVVlZZqrTwyuulVxZfWm3leqkGvU5s8GE6Qk7gc39wF-6hufqsj9Ht3gFjUVe3II7cIKBDq-rChXjwVS09yj3hoaOK3ZDGgTmtJw5gH1k_9ynb9U59xmAjmEwq_Gd5V-ziT2z0tqjyNy919ggW_fd14pRvXlOnnvpxK_Xjv_6Ax_DQ0lbypmt9And0eQj7XSHLm0O4P7Vb9E_h88dkXWRkpoygB_0imeP7VwS5MXlrpTfm6qQkn4p6syKzpmqVNa1I94ascjLWm7WuyKwwiYu_Y7dNUxGbv_SaTNBYDD9-Bouzd_PR2LXVHFzF4mHtKkPmkMtzjGCUyjEyjSOtlUbKoWmeiUCxMMfVIRHGsWY58kzNMorhO9cYFHF6BHvlqtTPgZiCSxhbB8IQQMVYqmjKAxVkSYZjUOaA38-iXHdJO2Qb7IRCno-mknIppIGANBCQBgIOHPezLZNqKREpv7o5cLIz_9uHhjRCfonjnfZ4kGidZsslKfWqqWTAoxAJZvz3HsKQbOEPHTjq8LN9uIWkA3wHWNt2kxh8twXh0iYI7-Bx_L83nsKD8Xx6IS8ml-9fwEF3CtNIHl_CXr1p9AnSsDp91VrdT6vJL64 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2Vola98FGoSKHUB67JJrHjdY7VltVuYauKbVE5WYnjlEA3G20SifbXM87HwlZw6TV2Ytl-k3kjP88AfNAhZYJratM4jm2mQ7S5KGC20EGghn6Uxk2e7tk5n1yxs-vgegtEfxemEe2rOHPy24WTZ98bbWWxUINeJza4mI2QE7jcHRRJOngCT9FkXd7H6d35AWNBW7sgDGzPo8NO2YU_48EPtXAod4SDziq0fRp65sae2IMdZP7cpWzTQ_VZg41oMipx3dK24MW_GOlDYeVfnmr8HL71c2wFKj-duooddf8g_eNjFuEFPOvoKzlpe7yELZ3vw05b0PJuH3Zn3VH9K7j5EhVZQubKCHvQP5JLnENJkCOT006CY55Oc_I1q1ZLMq_LRmHTiHXvyDIlE70qdEnmmUlg_Au7reqSdHlMb8kUjcbw5NdwNf54OZrYXVUHW7FwWNnKkDrk9BwjGaVSjFDDQGulkXpomibCU8xP8S8RCeNgkxT5pmYJxTCeawyOOD2A7XyZ6zdATOEljLE9YYigYixWNOae8pIowTEos8Dtd1IWbfIO2QQ9vpBno5mkXAppYCANDKSBgQWH_Y7LqFxIRMufbhYcbWBg_VGfBsgzcbzjHhMSrdQcvUS5Xtal9HjgI9EM_99DGLIt3KEFBy2G1h_vYGkB3wDXut0kCN9sQcg0icJbiBw-9sVj2L04HcvP0_NPb2GvvYxplI_vYLta1foI2VgVv28M7zcvozIu |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+Screening+Tests+for+Determining+In+Vitro+Susceptibility+of+Herpes+Simplex+Virus+Clinical+Isolates&rft.jtitle=Journal+of+Clinical+Microbiology&rft.au=Pedro+de+la+Iglesia&rft.au=Santiago+Mel%C3%B3n&rft.au=Beatriz+L%C3%B3pez&rft.au=Mercedes+Rodriguez&rft.date=1998-08-01&rft.pub=American+Society+for+Microbiology&rft.issn=0095-1137&rft.eissn=1098-660X&rft.volume=36&rft.issue=8&rft.spage=2389&rft_id=info:doi/10.1128%2Fjcm.36.8.2389-2391.1998&rft_id=info%3Apmid%2F9666034&rft.externalDBID=n%2Fa&rft.externalDocID=jcm_36_8_2389 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-1137&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-1137&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-1137&client=summon |